Posted by: Audrey Erbes | October 28, 2013

Where are the Biotech Jobs? Plus Life Science Events and Jobs in CA

Genetic Engineering and Biotechnology News includes their take on the growth of biotech clusters in the U.S. in today’s issue. Unlike Luke Timmerman they still attribute the largest region status to San Francisco with Boston listed as number 2 but also speak to the growth of other clusters in their list of the top 10 areas to seek employment in their article entitled “U.S. Hot Spots for Biotech Jobs: Thinking of relocating for work? Here’s where to start looking.”

GEN provides their review of growth based on developments in other regions of New York, Washington, DC area (including parts of Maryland and Virginia), Seattle, Raleigh/Durham Area of North Carolina, Chicago, Los Angeles, Philadephia and San Diego. Note the order is not related to ranking. Their methodology was straightforward—scrutinizing major job listing sites—LinkedIn, BioSpace, Medzilla, Indeed, and Monster.

One of our Bay Area readers Jim Powers challenges the Timmerman approach discussed in last week’s blog with some interesting points which he agreed to share:

  • “The listed companies are so diverse that there is no way to aggregate this data and come to any conclusion.
  • Some of these companies that hold this much cash plan to use the cash as a war chest for acquisitions and licensing ( Thermo-Fisher, Medivation, Clovis Bio..) not  for manufacturing or direct R&D.
  •  Some of these companies have fallen below the $100M club because they recently had an IPO and are now spending their cash (BlueBird Bio, Foundation Medical, Epizyme…)
  • A company, like Cepheid that is not listed on the $100M club, uses cash efficiently.  Cepheid has $380M revenues, $75M Cash and are valued at >$2.6B v. Epizyme, no revenue, $146M cash value $1B
  • Some of these companies have corporate HQ’s in the listed locale, but have operations in other parts of the world, e.g (Intarcia – Corporate – Boston, Operations – Hayward, CA; Astex, Corporate – Dublin, CA, R&D – UK, Thermo HQ – Boston; Operations – So. San Francisco, San Jose, etc.
  • There are privately held companies like Edison Pharma, 23andme, Neuropace who may very well have $100 million in cash but do not show up on this list.”

Highlights for the Upcoming Week

  • BioCentury This Week, See new program Webcast Starting Sunday, Oct. 27, 2013, 2013, Available anytime starting at 9:00 a.m. EDT; Topic:” Obamacare Glitches: Bad Rap for Healthcare IT;” Speaker: Dr. Farzad Mostashari, former National Coordinator for Health Information Technology at HHS
  • Bio2Device Group, Tuesday Morning, Oct. 29, 2013; Topic: “Connected point of Care: An emerging trend in Diagnostics Industry;” Speaker: Mohan Uttarwar, founder and CEO of OncoMDx/Core Diagnostics Lab
  • WIB, Tuesday Evening, Oct. 29, 2013; Event: “WIB–San Francisco Bay Area Presents the “Pivotal Changes” Panel;” Panelists: Deanna Kosaraju, Founder and CEO of Global Tech Women; Gerry Hansen, Hansen Coaching and Consulting; Lyn Christenson, Linkages Group and Christine Fera, Director of Contract Originations at Lighthouse Capital Partners
  • Janssen Labs, Tuesday Mid-Day, Oct. 29, 2013; Event: “Meet With… the JJIC/JJDC;”Presenters: Jeff Calcagno, Principal, Venture Investments, JJDC; Thomas Gustafson, VP Cardiovascular Medicine Innovation, JJIC; Adam Keeney, VP Head of Transactions, JJIC;  Arturo Molina, VP Oncology Innovation, JJIC;  Jackie Papkoff, VP Immunology Innovation, JJIC;  Guy Seabrook, VP Neuroscience Innovation, JJIC; Asish Xavier, VP Venture Investments, JJDC
  • HBA Webinar, Tuesday Morning, Oct. 29, 2013; Topic: “Career Conversation 1 – Controlling Your Destiny: Recognizing Themes, Making Choices;” Speakers: Marian Ruderman, PhD , senior fellow and director, research horizons, Center for Creative Leadership; Nancy Miller-Rich, group vice president, new ventures and strategic commercial development, Merck; Laurie Wessels, executive coach and president, Wessels Group, Inc.
  • Fierce Biotech, Tuesday Morning, Oct. 29, 2013; Event: “Biomarkers of Renal Toxicity in Nonclinical Safety Assessment Studies – Analytical and Biological Validation;” Co–presenters:Dr. Adam Aulbach, DVM, DACVP, and Mark J. Cameron, MS.
  • ASQ NCDG, Wednesday Evening, Oct. 30, 2013; Topic: “Quality by Design and Design for Manufacturability;” Moderator: Thomas Lypka, CEO TSL Quality Inc, RAC; Speaker: Thomas A. Little, President of Thomas A. Little Consulting (TLC)
  • Second HealthTech Conference, Wednesday, October 30, 2013; Event: “The HealthTech Conference: Building a Business in the New Healthcare Ecosystem”


Highlights for Business Development Course in Dec.

UC Berkeley Extension Course, Thursday and Friday, Dec. 5-6, 2013; Course: “Life Science Business Development,” (formerly known as Biotechnology Business Development); Lead Instructor: Audrey S. Erbes, Ph.D., Principal, Erbes & Associates and blog; Guest Speakers: Allison Dupuy, Ph.D., Senior Director in the Life Sciences division of Simon-Kucher & Partners; Harold (Hal) Etterman, MBA, CEO, Knight Financial Plans & Services, LLC; Carolyn Feamster, MBA, a business strategy and analysis consultant; Gilbert R. Mintz, Ph.D., President of GRM Associates; Ginger Dreger, J.D., M.S., partner in Arnold & Porter LLP’s intellectual property practice group; Chris Dokomajilar, Director, Business Intelligence, BioCentury; Location: Downtown University of California, Berkeley Extension, 425 Market St., 8th Floor, San Francisco, CA 94105; Cost: Fall term—fee: $895, (440.8-001). Register at

Next week I’ll be sharing details for the upcoming business and marketing courses in the spring. All three of my classes are now included in Life Science Business professional program at UC Berkeley Extension. Life Science Product Marketing: It’s All in the Plan course will be held in downtown San Francisco (Thursday evenings starting Feb. 13 and ending March 27) as well as Life Science Business and Marketing: Their Integral Role for Success (April 10-11) will also be taught in downtown San Francisco.

Find all the details for these upcoming events plus those through March 2014 in Audreys picks Oct. 28 2013 by right clicking on the highlighted title. You can also download the pfd of Jobs That Crossed My Desk Through Oct. 28, 2013 by right clicking as well. This latter list includes jobs I discovered this past week as well as the previous two weeks.



Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s


%d bloggers like this: